The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A prospective multicenter, single blinded, randomized phase III trial to compare the efficacy of ramosetron, aprepitant and dexamethasone with ondansetron, aprepitant, and dexamethasone for preventing chemotherapy-induced nausea and vomiting: KCSG PC10-21.
Hyo Jung Kim
No relevant relationships to disclose
Eun-Kee Song
No relevant relationships to disclose
Jun Suk Kim
No relevant relationships to disclose
Jin Seok Ahn
No relevant relationships to disclose
Hwan Jung Yun
No relevant relationships to disclose
Yo Han Cho
No relevant relationships to disclose
Keon Uk Park
No relevant relationships to disclose
Si-Young Kim
No relevant relationships to disclose
JoungSoon Jang
No relevant relationships to disclose
Sang-We Kim
No relevant relationships to disclose
Hyun Woo Lee
No relevant relationships to disclose
Se Ryeon Lee
No relevant relationships to disclose
Yang Soo Kim
No relevant relationships to disclose
Soon-Nam Lee
No relevant relationships to disclose
Yoon-Ho Ko
No relevant relationships to disclose
Hwa Jung Kim
No relevant relationships to disclose
Jin Hyoung Kang
No relevant relationships to disclose
Sang Won Shin
No relevant relationships to disclose